Merk He followsJohnson and Johnson leadershipAnd reporting an expected financial strike fromDefinitionsIt is imposed by the Trump administration.
In a profit call on April 24, executive officials said they expect $ 200 million costs of tariff costs in 2025. MERCK reduced profit expectations throughout the whole year from $ 8.88-9.03 dollars per share to 8.82-8.97 dollars per share.
The news comes a week after the CEOs of J & J expect that they expect $ 400 million of expenses caused by the customs tariff in 2025.
“The effect will come primarily from the current definitions that were implemented” between the United States and China, and to a lesser extent, Canada and Mexico. “
in spite ofto threatenPharmaceutical definitions on the horizon following the Ministry of Commerce announced on April 14 that the Trump administration is investigating the effects of national security on pharmaceutical imports, Davis does not seem particularly concern.
“With regard to the additional additional tariffs by the United States specifically on medicines, the global supply chain and current inventory levels put us in a good position to move in the possible effects in the short term,” he said.
When asked during the profit call about how Merck prepared for potential pharmaceutical tariffs, Davis said that the company has set ways to “re -manufacture”, including changing the priorities of current factories, bringing external manufacturing, and building internal manufacturing.
Davis said Merck has invested $ 12 billion in manufacturing in the United States since 2018 and plans to invest an additional amount of $ 9 billion until 2028, adding that the company’s investments “lead to more our products for patients in the United States in the United States in addition to more opportunities for export.”
Enlargement outside.Merck is not the only drug maker that highlights American investment.
J&S executive officials said in March that the company is planning to invest $ 55 billion in American manufacturing over the next four years. In February, Eli Lily Executive officials said the company will invest at least 27 billion dollars to open four new factories based in the United States over the next five years.
The three drug makers said that their decisions to expand the manufacture of the United States are due to the 2018 tax and tax laws law, which reduced the local tax rate of pharmaceutical companies.
Joaquin Duato, CEO of J & J: said:
The rapidly ranted.MERCK’s global sales of Q1 2025 15.5 billion dollars, a decrease of 2 % from the first quarter of 2024.
Despite the decrease in profit expectations 2025, the company said it still expects sales around the world to decrease between 64.1 billion dollars and $ 65.6 billion this year.
MERCK is also preparing for its Costruda drug drugs, which alone represents more than 45 % of the global pharmaceutical drug sales, to meet the expiration of patents in 2028. KEYTRUDA sales increased by 4 % during the quarter to 7.2 billion dollars, up from $ 6.9 billion in the same quarter in the past year, despite partners’ expectations.
This was the report It was originally published by Healthcare drink.
This story was originally shown on Fortune.com
https://fortune.com/img-assets/wp-content/uploads/2025/04/GettyImages-2113284075-e1745604709378.jpg?resize=1200,600
Source link